Moderna COVID-19 vaccine was linked to myocarditis or myopericarditis at 28 d (4.2 events/100 000 persons)

Konstantin A Krychtiuk; L Kristin Newby

doi:10.7326/J22-0021

Moderna COVID-19 vaccine was linked to myocarditis or myopericarditis at 28 d (4.2 events/100 000 persons)

Ann Intern Med. 2022 May;175(5):JC58. doi: 10.7326/J22-0021. Epub 2022 May 3.

Authors

Konstantin A Krychtiuk¹, L Kristin Newby¹

Affiliation

¹ Duke Clinical Research Institute, Durham, North Carolina, USA (K.A.K., L.K.N.).

PMID: 35500266
DOI: 10.7326/J22-0021

Abstract

Husby A, Hansen JV, Fosbøl E, et al. SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study. BMJ. 2021;375:e068665. 34916207.

Publication types

Comment

MeSH terms

2019-nCoV Vaccine mRNA-1273* / adverse effects
COVID-19* / epidemiology
COVID-19* / prevention & control
Cohort Studies
Humans
Myocarditis* / chemically induced
Myocarditis* / epidemiology
SARS-CoV-2
Vaccination / adverse effects

Substances

2019-nCoV Vaccine mRNA-1273